

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.41845259 |
| 2 | negative thymic T cell selection (GO:0045060) | 5.99291647 |
| 3 | negative T cell selection (GO:0043383) | 5.89148162 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.74382078 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.63360780 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.63360780 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.51496635 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.50170319 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.49881842 |
| 10 | thymic T cell selection (GO:0045061) | 5.44754736 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.32381187 |
| 12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.25679356 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.22632488 |
| 14 | positive T cell selection (GO:0043368) | 5.00998654 |
| 15 | B cell receptor signaling pathway (GO:0050853) | 4.97543570 |
| 16 | T cell selection (GO:0045058) | 4.94919662 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.86441691 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.82289159 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.80393018 |
| 20 | response to interleukin-15 (GO:0070672) | 4.68266113 |
| 21 | leukocyte aggregation (GO:0070486) | 4.56630684 |
| 22 | tolerance induction (GO:0002507) | 4.40831278 |
| 23 | T cell migration (GO:0072678) | 4.39311995 |
| 24 | positive regulation of granulocyte differentiation (GO:0030854) | 4.25531031 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.22395406 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 4.18144529 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 4.15078352 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.15009283 |
| 29 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.00666091 |
| 30 | Peyers patch development (GO:0048541) | 4.00666091 |
| 31 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.91474762 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.90822587 |
| 33 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.88060457 |
| 34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.74776472 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70246346 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 3.65535506 |
| 37 | B cell homeostasis (GO:0001782) | 3.63007987 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58926740 |
| 39 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.57609681 |
| 40 | T cell homeostasis (GO:0043029) | 3.51529620 |
| 41 | detection of bacterium (GO:0016045) | 3.48801350 |
| 42 | germinal center formation (GO:0002467) | 3.45925945 |
| 43 | natural killer cell differentiation (GO:0001779) | 3.43338577 |
| 44 | response to muramyl dipeptide (GO:0032495) | 3.42179890 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40605879 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 3.40605879 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40605879 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40605879 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40605879 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 3.40605879 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.39898057 |
| 52 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.35875129 |
| 53 | lymphocyte homeostasis (GO:0002260) | 3.31924810 |
| 54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28812097 |
| 55 | negative regulation of phagocytosis (GO:0050765) | 3.27162203 |
| 56 | detection of other organism (GO:0098543) | 3.26565134 |
| 57 | activated T cell proliferation (GO:0050798) | 3.26289027 |
| 58 | positive regulation of Rap GTPase activity (GO:0032854) | 3.25531772 |
| 59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.23690232 |
| 60 | T cell receptor signaling pathway (GO:0050852) | 3.22651870 |
| 61 | positive regulation of interleukin-2 production (GO:0032743) | 3.21916657 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.19733097 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.19733097 |
| 64 | response to type I interferon (GO:0034340) | 3.19717625 |
| 65 | T cell costimulation (GO:0031295) | 3.18631049 |
| 66 | lymphocyte costimulation (GO:0031294) | 3.15372720 |
| 67 | defense response to protozoan (GO:0042832) | 3.12847305 |
| 68 | regulation of granulocyte differentiation (GO:0030852) | 3.11773775 |
| 69 | cellular response to interleukin-4 (GO:0071353) | 3.09773495 |
| 70 | regulation of histone H3-K27 methylation (GO:0061085) | 3.09318000 |
| 71 | signal complex assembly (GO:0007172) | 3.08331050 |
| 72 | histone H3-K36 demethylation (GO:0070544) | 3.07621398 |
| 73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03909529 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.03032901 |
| 75 | interferon-gamma production (GO:0032609) | 3.02533976 |
| 76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00649696 |
| 77 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00491820 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98271787 |
| 79 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98271787 |
| 80 | regulation of interleukin-4 production (GO:0032673) | 2.97311362 |
| 81 | regulation of alpha-beta T cell activation (GO:0046634) | 2.95818295 |
| 82 | positive regulation of interleukin-4 production (GO:0032753) | 2.93571695 |
| 83 | response to protozoan (GO:0001562) | 2.92300536 |
| 84 | leukocyte homeostasis (GO:0001776) | 2.92078043 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.89775026 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89026638 |
| 87 | positive regulation of isotype switching (GO:0045830) | 2.88669867 |
| 88 | B cell proliferation (GO:0042100) | 2.88198112 |
| 89 | positive regulation of B cell activation (GO:0050871) | 2.86171859 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84411664 |
| 91 | response to interleukin-4 (GO:0070670) | 2.84302256 |
| 92 | mast cell activation (GO:0045576) | 2.83343822 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.83129772 |
| 94 | T cell lineage commitment (GO:0002360) | 2.81709672 |
| 95 | myeloid dendritic cell activation (GO:0001773) | 2.80155000 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78409435 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.78205946 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.78205946 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 2.75939658 |
| 100 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.74532866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 4.78178542 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01788469 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.91545827 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.56922508 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.38357799 |
| 6 | MAF_26560356_Chip-Seq_TH1_Human | 2.94954983 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79903681 |
| 8 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.70022863 |
| 9 | UTX_26944678_Chip-Seq_JUKART_Human | 2.68654284 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.63804920 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.60656618 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.59423968 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56639884 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55231554 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.55107406 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53943165 |
| 17 | MAF_26560356_Chip-Seq_TH2_Human | 2.49995759 |
| 18 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.45504976 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.42430998 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.38401802 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37097703 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.24939142 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24405184 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15534813 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13243713 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.12805705 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10022209 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04625196 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.02497467 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02259135 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01776176 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98927429 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.94028854 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93923888 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91281761 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.91153131 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83337417 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81890095 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81698045 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74960061 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.74254568 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73885282 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70901993 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68037016 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67942541 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64535208 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58241030 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56813704 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56266478 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51988757 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51711215 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50908955 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50458387 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47262541 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45870016 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41481502 |
| 57 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41429077 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40739288 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38282295 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.32250223 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28901857 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28613310 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28004009 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27779099 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27407846 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25664694 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24113599 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23438161 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22574393 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21648111 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21316279 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20238389 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19446897 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16764256 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11992423 |
| 76 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11266821 |
| 77 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10165187 |
| 78 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01916070 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01395000 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01006795 |
| 81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00819427 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00188969 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99449837 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99320231 |
| 85 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98598097 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97225055 |
| 87 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96836111 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96789467 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95320175 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94505816 |
| 91 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.92466646 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92341151 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90509662 |
| 94 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.90470754 |
| 95 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90118174 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89820613 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89109497 |
| 98 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88589479 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88451535 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87657627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.78902120 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.61689269 |
| 3 | MP0003436_decreased_susceptibility_to | 3.55544098 |
| 4 | MP0005671_abnormal_response_to | 3.49036318 |
| 5 | MP0001800_abnormal_humoral_immune | 3.48776872 |
| 6 | MP0000685_abnormal_immune_system | 3.35847533 |
| 7 | MP0001790_abnormal_immune_system | 3.21642396 |
| 8 | MP0005387_immune_system_phenotype | 3.21642396 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.07154721 |
| 10 | MP0003303_peritoneal_inflammation | 2.98990809 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.86088484 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.73648358 |
| 13 | MP0002398_abnormal_bone_marrow | 2.73083946 |
| 14 | MP0002723_abnormal_immune_serum | 2.70716767 |
| 15 | MP0001819_abnormal_immune_cell | 2.68377191 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.63141406 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.59133478 |
| 18 | MP0001873_stomach_inflammation | 2.58900543 |
| 19 | MP0000703_abnormal_thymus_morphology | 2.56832218 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.38877968 |
| 21 | MP0005025_abnormal_response_to | 2.37429788 |
| 22 | MP0000716_abnormal_immune_system | 2.36019558 |
| 23 | MP0002405_respiratory_system_inflammati | 2.13101545 |
| 24 | MP0002722_abnormal_immune_system | 2.12493476 |
| 25 | MP0003724_increased_susceptibility_to | 2.12137656 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.11282586 |
| 27 | MP0002419_abnormal_innate_immunity | 2.04537554 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.95320023 |
| 29 | MP0002429_abnormal_blood_cell | 1.94154132 |
| 30 | MP0005310_abnormal_salivary_gland | 1.93114309 |
| 31 | MP0004947_skin_inflammation | 1.85833091 |
| 32 | MP0003866_abnormal_defecation | 1.82855361 |
| 33 | MP0008057_abnormal_DNA_replication | 1.79204611 |
| 34 | MP0009785_altered_susceptibility_to | 1.78005181 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.77178759 |
| 36 | MP0002009_preneoplasia | 1.71648632 |
| 37 | MP0004381_abnormal_hair_follicle | 1.68439638 |
| 38 | MP0009278_abnormal_bone_marrow | 1.62594307 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.58755345 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.55471457 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.50500696 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.48758241 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.48123203 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.38839400 |
| 45 | MP0005451_abnormal_body_composition | 1.37574975 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.36236243 |
| 47 | MP0000490_abnormal_crypts_of | 1.30711102 |
| 48 | MP0002006_tumorigenesis | 1.26173771 |
| 49 | MP0008260_abnormal_autophagy | 1.21029049 |
| 50 | MP0002933_joint_inflammation | 1.18471441 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.17327280 |
| 52 | MP0006082_CNS_inflammation | 1.15453825 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.13252695 |
| 54 | MP0001851_eye_inflammation | 1.11774809 |
| 55 | MP0001853_heart_inflammation | 1.11203618 |
| 56 | MP0004510_myositis | 1.01207845 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.00871479 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 0.96396822 |
| 59 | MP0000858_altered_metastatic_potential | 0.95617564 |
| 60 | MP0008469_abnormal_protein_level | 0.95514623 |
| 61 | MP0003183_abnormal_peptide_metabolism | 0.94446093 |
| 62 | MP0002132_abnormal_respiratory_system | 0.91587298 |
| 63 | MP0008961_abnormal_basal_metabolism | 0.88614107 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.87591818 |
| 65 | MP0001663_abnormal_digestive_system | 0.86204395 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.85635362 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.84246778 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.84246778 |
| 69 | MP0005076_abnormal_cell_differentiation | 0.82734383 |
| 70 | MP0008569_lethality_at_weaning | 0.80120850 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.77814111 |
| 72 | MP0004859_abnormal_synaptic_plasticity | 0.75019528 |
| 73 | MP0003111_abnormal_nucleus_morphology | 0.73071016 |
| 74 | MP0002163_abnormal_gland_morphology | 0.73022018 |
| 75 | MP0000313_abnormal_cell_death | 0.72571836 |
| 76 | MP0003077_abnormal_cell_cycle | 0.69487649 |
| 77 | MP0010094_abnormal_chromosome_stability | 0.69403453 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.66558278 |
| 79 | MP0003091_abnormal_cell_migration | 0.66331144 |
| 80 | MP0000350_abnormal_cell_proliferation | 0.65887529 |
| 81 | MP0003787_abnormal_imprinting | 0.64136660 |
| 82 | MP0008874_decreased_physiological_sensi | 0.64060750 |
| 83 | MP0003045_fibrosis | 0.63457198 |
| 84 | MP0005621_abnormal_cell_physiology | 0.58305082 |
| 85 | MP0001730_embryonic_growth_arrest | 0.57764617 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.57568800 |
| 87 | MP0005166_decreased_susceptibility_to | 0.55651221 |
| 88 | MP0002254_reproductive_system_inflammat | 0.53287641 |
| 89 | MP0002083_premature_death | 0.53074274 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.49383807 |
| 91 | MP0003693_abnormal_embryo_hatching | 0.48505976 |
| 92 | MP0009763_increased_sensitivity_to | 0.47569162 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.47144475 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.45513370 |
| 95 | MP0003448_altered_tumor_morphology | 0.43713653 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.42524421 |
| 97 | MP0009115_abnormal_fat_cell | 0.38820353 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.38819266 |
| 99 | MP0005535_abnormal_body_temperature | 0.38754973 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.38423956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 5.42518045 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.32600211 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.85453677 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.76287571 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 4.43808777 |
| 6 | Meningitis (HP:0001287) | 4.42384684 |
| 7 | Recurrent viral infections (HP:0004429) | 4.33513085 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.21023286 |
| 9 | Lymphopenia (HP:0001888) | 4.10389417 |
| 10 | Increased IgE level (HP:0003212) | 3.96604109 |
| 11 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.83838187 |
| 12 | IgM deficiency (HP:0002850) | 3.74292018 |
| 13 | Cellulitis (HP:0100658) | 3.73697239 |
| 14 | Colitis (HP:0002583) | 3.73476760 |
| 15 | T lymphocytopenia (HP:0005403) | 3.71742808 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.71218471 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 3.70012088 |
| 18 | Vasculitis (HP:0002633) | 3.66720364 |
| 19 | Pustule (HP:0200039) | 3.66413447 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.61390847 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.55957011 |
| 22 | Inflammation of the large intestine (HP:0002037) | 3.52120765 |
| 23 | Abnormality of T cells (HP:0002843) | 3.51794999 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44723563 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44723563 |
| 26 | Papilloma (HP:0012740) | 3.43525189 |
| 27 | Verrucae (HP:0200043) | 3.43525189 |
| 28 | Abnormality of the fingertips (HP:0001211) | 3.40616518 |
| 29 | Myositis (HP:0100614) | 3.39070773 |
| 30 | Encephalitis (HP:0002383) | 3.38935797 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 3.38863245 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.37949981 |
| 33 | Recurrent bronchitis (HP:0002837) | 3.26951484 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26426889 |
| 35 | Papilledema (HP:0001085) | 3.24898623 |
| 36 | Obstructive lung disease (HP:0006536) | 3.16444435 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16444435 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.15279853 |
| 39 | Recurrent sinusitis (HP:0011108) | 3.12259881 |
| 40 | Stomatitis (HP:0010280) | 3.09283040 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 3.07103690 |
| 42 | Abnormality of macrophages (HP:0004311) | 3.06954042 |
| 43 | Basal cell carcinoma (HP:0002671) | 3.04501975 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 3.01845575 |
| 45 | Granulocytopenia (HP:0001913) | 2.96909675 |
| 46 | Recurrent skin infections (HP:0001581) | 2.90133039 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.84544847 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.84210496 |
| 49 | IgG deficiency (HP:0004315) | 2.82676138 |
| 50 | Optic neuritis (HP:0100653) | 2.82093872 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.82093872 |
| 52 | Emphysema (HP:0002097) | 2.80502703 |
| 53 | B lymphocytopenia (HP:0010976) | 2.77494240 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.74818072 |
| 55 | Orchitis (HP:0100796) | 2.74730375 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.74070620 |
| 57 | IgA deficiency (HP:0002720) | 2.71917601 |
| 58 | Chest pain (HP:0100749) | 2.66920167 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.65380646 |
| 60 | Lymphoma (HP:0002665) | 2.64978841 |
| 61 | Viral hepatitis (HP:0006562) | 2.62408358 |
| 62 | Increased IgM level (HP:0003496) | 2.62317549 |
| 63 | Osteomyelitis (HP:0002754) | 2.60091075 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51922213 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.45425524 |
| 66 | Restrictive lung disease (HP:0002091) | 2.42136578 |
| 67 | Sepsis (HP:0100806) | 2.41747246 |
| 68 | Hypochromic anemia (HP:0001931) | 2.39694842 |
| 69 | Chronic diarrhea (HP:0002028) | 2.38207492 |
| 70 | Hypoplasia of the thymus (HP:0000778) | 2.33227569 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31252369 |
| 72 | Chronic otitis media (HP:0000389) | 2.29796935 |
| 73 | Urticaria (HP:0001025) | 2.24537660 |
| 74 | Eosinophilia (HP:0001880) | 2.21480612 |
| 75 | Leukocytosis (HP:0001974) | 2.20102041 |
| 76 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.19180936 |
| 77 | Obstructive sleep apnea (HP:0002870) | 2.19037356 |
| 78 | Deep palmar crease (HP:0006191) | 2.17193270 |
| 79 | Epistaxis (HP:0000421) | 2.14642416 |
| 80 | Gingivitis (HP:0000230) | 2.12877840 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.12733125 |
| 82 | Seborrheic dermatitis (HP:0001051) | 2.11619159 |
| 83 | Annular pancreas (HP:0001734) | 2.10105840 |
| 84 | Abnormality of eosinophils (HP:0001879) | 2.07117565 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.06816168 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04470041 |
| 87 | Recurrent otitis media (HP:0000403) | 2.02057734 |
| 88 | Teleangiectasia of the skin (HP:0100585) | 2.01647935 |
| 89 | Hemoptysis (HP:0002105) | 1.97705614 |
| 90 | Skin ulcer (HP:0200042) | 1.94832048 |
| 91 | Pulmonary embolism (HP:0002204) | 1.94565449 |
| 92 | Fatigue (HP:0012378) | 1.94233075 |
| 93 | Keratoconjunctivitis (HP:0001096) | 1.88898685 |
| 94 | Hepatitis (HP:0012115) | 1.88779586 |
| 95 | Recurrent pneumonia (HP:0006532) | 1.84944582 |
| 96 | Nasal polyposis (HP:0100582) | 1.83471378 |
| 97 | Acute hepatic failure (HP:0006554) | 1.81063466 |
| 98 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80813798 |
| 99 | Villous atrophy (HP:0011473) | 1.80813798 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.80554360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.55956517 |
| 2 | PRPF4B | 4.47076317 |
| 3 | RIPK4 | 3.48000537 |
| 4 | MAP3K10 | 3.04776414 |
| 5 | SMG1 | 2.62304936 |
| 6 | MAP3K13 | 2.40844551 |
| 7 | TRIB3 | 2.20454245 |
| 8 | ERN1 | 2.19710779 |
| 9 | CDK12 | 2.11937727 |
| 10 | SIK2 | 2.09903262 |
| 11 | TYK2 | 2.08027208 |
| 12 | TNK2 | 2.07870065 |
| 13 | BTK | 1.89261185 |
| 14 | MAP3K14 | 1.87251119 |
| 15 | TXK | 1.87114712 |
| 16 | FES | 1.77026139 |
| 17 | PASK | 1.74332683 |
| 18 | FGFR4 | 1.73129160 |
| 19 | SIK3 | 1.72726359 |
| 20 | IRAK4 | 1.71391880 |
| 21 | SYK | 1.68033908 |
| 22 | ZAP70 | 1.58452076 |
| 23 | ITK | 1.57974864 |
| 24 | GRK6 | 1.53535578 |
| 25 | JAK3 | 1.51676371 |
| 26 | BLK | 1.48528869 |
| 27 | IKBKE | 1.40284193 |
| 28 | MAP2K3 | 1.36788099 |
| 29 | CAMKK1 | 1.35095216 |
| 30 | HCK | 1.30521545 |
| 31 | JAK1 | 1.27260373 |
| 32 | CSK | 1.25163376 |
| 33 | EEF2K | 1.22690415 |
| 34 | CDK4 | 1.22455282 |
| 35 | MARK2 | 1.21769766 |
| 36 | LCK | 1.18225336 |
| 37 | FGFR3 | 1.12163746 |
| 38 | SIK1 | 1.08847643 |
| 39 | HIPK2 | 1.06448735 |
| 40 | LYN | 1.04130403 |
| 41 | MAPK12 | 1.03716784 |
| 42 | NLK | 1.02609009 |
| 43 | TBK1 | 1.00870849 |
| 44 | MAPK11 | 0.99871376 |
| 45 | ICK | 0.99240626 |
| 46 | CSF1R | 0.97244359 |
| 47 | MAP3K7 | 0.93237751 |
| 48 | TAOK1 | 0.89134357 |
| 49 | BRD4 | 0.88760743 |
| 50 | CDC42BPA | 0.88483246 |
| 51 | PDK1 | 0.86936502 |
| 52 | PRKCQ | 0.86148176 |
| 53 | TEC | 0.85451056 |
| 54 | MARK3 | 0.81371422 |
| 55 | JAK2 | 0.79452446 |
| 56 | MAP3K11 | 0.79377610 |
| 57 | IKBKB | 0.78873066 |
| 58 | KSR2 | 0.77691231 |
| 59 | MAP3K1 | 0.76874536 |
| 60 | TAOK2 | 0.76137344 |
| 61 | UHMK1 | 0.75258273 |
| 62 | PRKCH | 0.74822495 |
| 63 | TYRO3 | 0.73000679 |
| 64 | TAOK3 | 0.70691487 |
| 65 | CDK19 | 0.67484841 |
| 66 | STK10 | 0.63576868 |
| 67 | MAPK7 | 0.63016313 |
| 68 | PRKD2 | 0.61212662 |
| 69 | PIM1 | 0.60924532 |
| 70 | KIT | 0.60865566 |
| 71 | TESK2 | 0.58417665 |
| 72 | EPHB1 | 0.58345034 |
| 73 | MELK | 0.54289086 |
| 74 | IRAK2 | 0.50730844 |
| 75 | PDPK1 | 0.49035990 |
| 76 | PRKD3 | 0.48344460 |
| 77 | CAMKK2 | 0.47862371 |
| 78 | BMPR2 | 0.45522450 |
| 79 | LRRK2 | 0.44344921 |
| 80 | CDK6 | 0.43377815 |
| 81 | ALK | 0.43043111 |
| 82 | FGR | 0.42999627 |
| 83 | RPS6KC1 | 0.41133589 |
| 84 | RPS6KL1 | 0.41133589 |
| 85 | FYN | 0.41058035 |
| 86 | MAP2K2 | 0.40549091 |
| 87 | PKN2 | 0.39460397 |
| 88 | STK11 | 0.39067572 |
| 89 | MAPK4 | 0.38690699 |
| 90 | MAP3K8 | 0.38644639 |
| 91 | RET | 0.37519609 |
| 92 | SGK3 | 0.36889231 |
| 93 | CDK9 | 0.35999807 |
| 94 | CAMK4 | 0.33655459 |
| 95 | CHUK | 0.32472497 |
| 96 | PTK6 | 0.32016291 |
| 97 | MAP3K3 | 0.31902985 |
| 98 | FGFR2 | 0.30404289 |
| 99 | RPS6KA6 | 0.29099149 |
| 100 | MAP3K9 | 0.27869608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.10036164 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.00421993 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.85007428 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.70192298 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54339486 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.54247901 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.31231437 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09094503 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.08971834 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07042180 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.04919432 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.98341669 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95506147 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93388385 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.88799097 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.76147162 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76059695 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73224609 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68655663 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67056689 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.66595222 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61563018 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55635211 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.45935325 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44725606 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44366014 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41485092 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.41251363 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31621741 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26068045 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.24339230 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23337716 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22884001 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21264364 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19005475 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17701426 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16238976 |
| 38 | HTLV-I infection_Homo sapiens_hsa05166 | 1.14511978 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09078897 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.07761685 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05918047 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99758833 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.96378303 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95614823 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.93184161 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93027869 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91536443 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90555079 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87421737 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86917615 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86903854 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83852147 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83640654 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81835294 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.80416568 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80227531 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79094313 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.78888107 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78129088 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 0.76013640 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74933915 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72758541 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72276916 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69389297 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68576736 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68531415 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67765129 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65563217 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63918323 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63364824 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61382891 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60666399 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.59688490 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57817551 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56451123 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54199791 |
| 77 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54020873 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.51958489 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51162589 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48078457 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47640150 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47615759 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47285882 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.46153619 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45557088 |
| 86 | DNA replication_Homo sapiens_hsa03030 | 0.45496470 |
| 87 | Spliceosome_Homo sapiens_hsa03040 | 0.44694777 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44414433 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42685906 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.42351113 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42105265 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40124271 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.38508026 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37174825 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36844604 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36022127 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34723675 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34289074 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34200384 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | 0.33885148 |

